Calendrier des promotions Sun Pharma Advanced Research Company Limited
Calendrier avancé
Graphique simple
À propos de l'entreprise Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited, биофармацевтическая компания, занимается исследованиями и разработками фармацевтических продуктов в Индии и за рубежом. Он разрабатывает новые химические и биологические соединения, а также меняет состав продуктов с терапевтической направленностью на онкологию, нейродегенерацию, офтальмологию, дерматологию и иммунологию. plus de détailsParamètres de base
ISIN
INE232I01014
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 161.07 | 1 |
| P/BV | 96.76 | 1 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -57.57 | 0 |
| ROE | -121.28 | 0 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -0.0771 | 10 |
| Debt/Ratio | 0.0304 | 10 |
| Debt/Equity | 3.1 | 4 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | -1.65 | 0 |
| Rentabilité Ebitda, % | 47.46 | 6 |
| Rentabilité EPS, % | 0.0867 | 1 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 164.35 ₹ | 0 ₹ | 0 ₹ | -1.92 % | 0 % | 0 % |
| common.calendar.number_days.7d | 159.65 ₹ | 0 ₹ | 0 ₹ | 0.97 % | 0 % | 0 % |
| common.calendar.number_days.30d | 149.6 ₹ | 150.7 ₹ | 167.15 ₹ | 7.75 % | 0 % | 0 % |
| common.calendar.number_days.90d | 124.65 ₹ | 117.35 ₹ | 167.15 ₹ | 29.32 % | 0 % | 0 % |
| common.calendar.number_days.180d | 209.4 ₹ | 111.95 ₹ | 230.5 ₹ | -23.02 % | 0 % | 0 % |
| common.calendar.number_days.1y | 217.9 ₹ | 111.95 ₹ | 251.25 ₹ | -26.02 % | 0 % | 0 % |
| common.calendar.number_days.3y | 222.35 ₹ | 111.95 ₹ | 455.05 ₹ | -27.5 % | 0 % | 0 % |
| common.calendar.number_days.5y | 139.8 ₹ | 111.95 ₹ | 455.05 ₹ | 15.31 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 ₹ | 83.05 ₹ | 518.55 ₹ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 230.5 ₹ | 111.95 ₹ | 202.15 ₹ | -30.07 % | 0 % | 0 % |
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. Anilkumar Raghavan | Chief Executive Officer | N/A | 1968 (57 années) |
| Mr. Siu-Long Yao | Head Clinical Development | N/A | |
| Mr. Jaydeep Issrani | Senior General Manager of Business Development, Corporate Communication & Investor Relations | N/A | |
| Ms. Shanta Gupta | Chief Human Resource Officer | N/A | |
| Dr. Nitin K. Damle Ph.D. | Chief Innovation Officer | N/A | |
| Dr. Nitin Dharmadhikari | Chief Operating Officer | N/A | 1962 (63 année) |
| Mr. Anup Rathi | Chief Financial Officer | ||
| Ms. Kajal K. Damania | Company Secretary & Compliance Officer | ||
| Dr. Yashoraj Zala | Head of Drug Delivery Systems | ||
| Dr. Vikram K. Ramanathan | Head of Preclinical Development |
Informations sur l'entreprise
Adresse: India, Mumbai, 17/B Mahal Industrial Estate - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.sparc.life
Site web: https://www.sparc.life
